Crossmark

Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals

Published Online: 2017-09-19

Authors

Zia, Qamar

Mohammad, Owais

Rauf, Mohd Ahmar

Khan, Wasi

Zubair, Swaleha
License Information

Text and Data Mining valid from 2017-09-19

Version of Record valid from 2017-09-19
More Information

Article History

Received: 3 October 2016

Accepted: 15 August 2017

First Online: 19 September 2017

Competing Interests

: The authors declare that they have no competing interests.

Document is current